Phoenix Biotech Acquisition Stock Price, News & Analysis (NASDAQ:PBAX) $10.87 0.00 (0.00%) (As of 12/1/2023 ET) Add Compare Share Share Today's Range$10.87▼$10.8750-Day Range$10.83▼$10.9352-Week Range$10.22▼$11.83Volume20 shsAverage Volume379 shsMarket Capitalization$67.89 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media About Phoenix Biotech Acquisition Stock (NASDAQ:PBAX)Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. Phoenix Biotech Acquisition Corp. was incorporated in 2021 and is based in Oakland, California.Read More PBAX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PBAX Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive PBAX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Phoenix Biotech Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today12/01/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Holding & other investment offices Sub-IndustryN/A SectorUnclassified Current SymbolNASDAQ:PBAX CUSIPN/A CIK1870404 Webwww.phoenixbiotechacquisitioncorp.com Phone215-731-9450FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares6,246,000Free Float1,359,000Market Cap$67.89 million OptionableNot Optionable Beta0.06 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Christopher B. Ehrlich M.B.A. (Age 53)CEO & Director Dr. Douglas Carl Fisher M.B.A. (Age 47)M.D., President Mr. Daniel E. Geffken M.B.A. (Age 66)Chief Financial Officer Key CompetitorsCetus Capital AcquisitionNASDAQ:CETUAetherium AcquisitionNASDAQ:GMFIIndustrial Tech Acquisitions IINASDAQ:ITAQBukit Jalil Global Acquisition 1NASDAQ:BUJARevelstone Capital AcquisitionNASDAQ:RCACView All CompetitorsInstitutional OwnershipShaolin Capital Management LLCBought 158,877 shares on 11/21/2023Ownership: 0.801%Meteora Capital LLCBought 17,837 shares on 11/14/2023Ownership: 2.718%View All Institutional Transactions PBAX Stock Analysis - Frequently Asked Questions How have PBAX shares performed in 2023? Phoenix Biotech Acquisition's stock was trading at $10.2703 at the beginning of 2023. Since then, PBAX stock has increased by 5.8% and is now trading at $10.87. View the best growth stocks for 2023 here. Who are Phoenix Biotech Acquisition's major shareholders? Phoenix Biotech Acquisition's stock is owned by a number of institutional and retail investors. Top institutional investors include Meteora Capital LLC (2.72%) and Shaolin Capital Management LLC (0.80%). How do I buy shares of Phoenix Biotech Acquisition? Shares of PBAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:PBAX) was last updated on 12/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phoenix Biotech Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.